FDA issued a Warning Letter to Coral Pharmaceuticals LTD on 10/9/2019 as a result of this inspection.
483 Coral Pharmaceuticals May 2019
483 Coral Pharmaceuticals May 2019$119 - Not in Stock
FDA investigators audited the Coral Pharmaceuticals - Freeport City, Bahamas facility and issued inspectional observations (via FDA 483) on 24 May 2019.
- Category: Human Drugs
- Inspection end: 24 May 2019
- Location: Freeport City, Bahamas
- FEI: 3003301821
Pre-Order Not Available